Cite

HARVARD Citation

    Kwon, D. et al. (2021). Differential treatment outcomes in BRCA1/2‐, CDK12‐, and ATM‐mutated metastatic castration‐resistant prostate cancer. Cancer. 127 (12), pp. 1965-1973. [Online]. 
  
Back to record